Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(12 sites)
China
Sun Yat-sen Memorial Hospital, Guangzhou, Guangdong Sun Yat-sen University Cancer Center, Guangzhou, Guangdong Guangdong Provincial People's Hospital, Guangzhou, Guangdong The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou Henan Provincial People's Hospital, Zhengzhou, Henan The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi The First Hospital of Jilin University, Changchun, Jilin Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning Shengjing Hospital of China Medical University, Shenyang, Liaoning The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang